|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
1739 |
|
THIRTY-SECOND LEGISLATURE, 2024 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
relating to product labeling.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 486, Hawaii Revised Statutes, is amended by adding a new section to part V to be appropriately designated and to read as follows:
"§486- Human cells; product labeling;
requirements; penalties. (a)
No person doing business in the State shall knowingly or intentionally
expose any other person to a product developed or tested using human cells unless
the product bears a warning label containing:
(1) A disclaimer
that states that the product was developed or tested using one or more human
cells; and
(2) The address of
a website disclosing:
(A) The
origin of each human cell that was used to develop or test the product was
obtained;
(B) The
method by which each human cell that was used to develop or test the product was
obtained; and
(C) The
medical or scientific name, if any, of the human cell base line that was used
to develop or test the product.
(b)
Any person that fails to comply with the requirements of this section
shall be subject to a fine in amount not to exceed $ or imprisonment for a period not to
exceed , or both."
SECTION 2. This Act does not affect rights and duties
that matured, penalties that were incurred, and proceedings that were begun
before its effective date.
SECTION 3. New statutory material is underscored.
SECTION 4. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
Product Labeling; Human Cells; Penalties
Description:
Establishes labeling requirements for products that were developed or tested using human cells.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.